A New Oral Treatment Shows Promise for Anaplastic Thyroid Cancer
September 9, 2019
A new orally active inverse agonist of estrogen-related receptor gamma (ERRү) called DN200434 shows promise with regard to the diagnosis and treatment of anaplastic thyroid cancer.
